Estée Lauder reported third-quarter revenues of $3.71 billion, up 4.6% year on year and in line with analysts' expectations, while beating estimates on earnings per share and EBITDA. The results were part of a broader personal care earnings roundup in which nine tracked stocks collectively beat revenue consensus by 2.5% but issued next-quarter revenue guidance 3.5% below estimates. Among peers, USANA Health Sciences posted flat revenues of $250.2 million that topped expectations by 3.8%, and Herbalife reported a 7.8% revenue increase to $1.32 billion but saw its stock fall 22.9% after issuing weaker EBITDA guidance. Medifast's revenues dropped 34.3% to $76.04 million yet exceeded estimates by 9.9%, while Coty's revenues slipped 1.3% to $1.28 billion, slightly ahead of consensus.
Estee Lauder Companies IncEstée Lauder reported Q3 revenue up 4.6% to $3.71B, in line with estimates, and beat on EPS and EBITDA.
Coty Inc
Herbalife Nutrition Ltd
MEDIFAST INC
USANA Health Sciences Inc